VBIO Valion Bio, Inc.

Fundamentals / CIK 0001787740 / USD
Other share classes on CIK 0001787740: TIVC

Valion Bio, Inc. reported $32.47M in total assets and a net loss of $18.75M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open VBIO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2021 to 2025), reported in USD.

$2.88M$1.44M$0-$9.60MFY 2021 Revenue: $1.26MFY 2021 Net Income: -$8.49M2021FY 2022 Revenue: $1.84MFY 2022 Net Income: -$10.10M2022FY 2023 Revenue: $1.18MFY 2023 Net Income: -$8.24M2023FY 2024 Revenue: $780KFY 2024 Net Income: -$5.66M2024FY 2025 Net Income: -$8.88M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- $780K $1.18M $1.84M $1.26M
Cost of Revenue -- $778K $889K $1.54M $1.29M
Gross Profit -- $2.0K $287K $299K -$38K
Research & Development $3.13M $1.31M $1.66M $1.73M $878K
Selling, General & Admin $4.77M $3.16M $6.88M $8.67M $4.72M
Total Operating Expenses $7.90M $4.48M $8.53M $10.40M $5.59M
Operating Income -$7.90M -$4.48M -$8.24M -$10.10M -$5.63M
EBITDA -$7.80M -$4.47M -$8.24M -$10.09M -$5.62M
Interest Income $23K $6.0K -- -- --
Interest Expense $146K $0 -- -- --
Income Before Tax -- -- -$8.24M -$10.10M --
Income Tax Expense $0 $0 -- -- --
Net Income -$8.88M -$5.66M -$8.24M -$10.10M -$8.49M
Basic EPS -$7.84 -$19.68 -$176.80 -$1,774.15 -$4,132.65
Diluted EPS -- -$19.68 -$176.80 -$1,774.15 -$4,132.65
Basic Shares Outstanding 1.2M 287.4K 46.6K 5.7K 2.1K
Diluted Shares Outstanding -- 287.4K 46.6K 5.7K 2.1K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue -- -- -- $146K $86K $70K $180K $126K
Cost of Revenue -- -- -- $291K $32K $20K $419K $82K
Gross Profit -- -- -- -$145K $54K $50K -$239K $44K
Research & Development $2.70M $1.85M $1.28M $858K $655K $335K $333K $422K
Selling, General & Admin $3.72M $3.78M -- $1.48M $1.02M $1.04M $911K $1.05M
Total Operating Expenses $6.42M $5.63M $2.02M $2.34M $1.68M $1.38M $57K $1.48M
Operating Income -$6.42M -$5.63M -$1.98M -$2.48M -$1.68M -$1.38M -$298K -$1.43M
EBITDA -$5.58M -$5.18M -$1.97M -$2.48M -$1.68M -$1.38M -$298K -$1.43M
Interest Income $11K $24K $12K $4.0K $3.0K $4.0K -- $0
Interest Expense $691K $648K -- -- $0 $0 -- --
Net Income -$7.10M -$6.20M -$2.85M -$2.60M -$1.93M -$1.50M -$1.48M -$1.43M
Basic EPS -$2.17 -$2.23 -- -$1.97 -$2.19 -$2.52 -- -$3.93
Diluted EPS -- -- -- -- -$2.19 -$2.52 -- -$3.91
Basic Shares Outstanding 3.4M 2.9M -- 1.3M 881.3K 569.4K -- 364.2K
Diluted Shares Outstanding -- -- -- -- 881.3K 596.4K -- 364.0K

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $12.64M $2.00M $3.40M $3.52M $12.97M
Cash & Short-Term Investments $12.64M $2.00M $3.40M $3.52M $12.97M
Accounts Receivable, Net -- $69K $174K $107K $92K
Inventory $0 $319K $756K $863K $429K
Other Current Assets -- $89K -- -- --
Total Current Assets $13.01M $2.64M $4.65M $5.31M $14.29M
Property, Plant & Equipment, Net $12.64M $2.0K $122K $12K $11K
Goodwill $3.46M $0 -- -- --
Intangible Assets $2.24M $0 -- -- --
Other Non-Current Assets $124K $0 $34K $34K $49K
Total Non-Current Assets $18.60M $168K $505K $569K $747K
Total Assets $31.61M $2.81M $5.16M $5.88M $15.04M
Accounts Payable $264K $125K $713K $1.32M $789K
Deferred Revenue (Current) -- -- -- $0 $12K
Total Current Liabilities $646K $272K $1.40M $1.88M $1.22M
Other Non-Current Liabilities $48K $0 -- -- --
Total Non-Current Liabilities $6.79M $0 $176K $367K $545K
Total Liabilities $7.44M $272K $1.58M $2.25M $1.76M
Total Debt (incl. Leases) -- -- $369K $530K $708K
Common Stock $2.0K $1.0K $0 $0 $1.0K
Retained Earnings -$52.60M -$43.54M -$37.89M -$29.64M -$19.55M
Total Stockholders' Equity $16.80M $2.54M $3.58M $3.63M $13.27M
Total Equity $16.80M $2.54M $3.58M $3.63M $13.27M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Cash & Cash Equivalents $2.11M $7.21M $12.64M $3.45M $1.18M $669K $2.00M $2.19M
Cash & Short-Term Investments $2.11M $7.21M $12.64M $3.45M $1.18M $669K $2.00M $2.19M
Accounts Receivable, Net -- -- -- $19K $13K $13K $69K $9.0K
Inventory $750K $750K $0 $4.0K $283K $306K $319K $731K
Other Current Assets -- -- -- -- $74K -- $89K --
Total Current Assets $3.38M $8.65M $13.01M $3.74M $1.84M $1.26M $2.64M $3.16M
Property, Plant & Equipment, Net $12.34M $12.64M $12.64M $12K $120K $118K $2.0K $119K
Goodwill $3.46M $3.46M $3.46M -- -- -- $0 --
Intangible Assets $2.24M $2.24M $2.24M $2.24M -- -- $0 --
Other Non-Current Assets $214K $210K $124K $23K $2.0K $2.0K $0 --
Total Non-Current Assets $29.09M $29.56M $18.60M $2.49M $2.67M $2.52M $168K $231K
Total Assets $32.47M $38.22M $31.61M $6.23M $4.51M $3.78M $2.81M $3.39M
Accounts Payable $639K $629K $264K $465K $234K $438K $125K $333K
Total Current Liabilities $3.05M $2.62M $646K $638K $821K $741K $272K $560K
Other Non-Current Liabilities $454K $251K $48K -- -- -- $0 --
Total Non-Current Liabilities $17.54M $17.05M $6.79M $0 $0 $0 $0 $0
Total Liabilities $20.59M $19.67M $7.44M $638K $821K $741K $272K $560K
Total Debt (incl. Leases) $10.02M $10.13M -- -- -- -- -- --
Common Stock $2.0K $2.0K $2.0K $2.0K $1.0K $1.0K $1.0K $1.0K
Retained Earnings -$66.51M -$59.03M -$52.60M -$49.62M -$46.98M -$45.04M -$43.54M -$42.06M
Total Stockholders' Equity $4.25M $11.06M $16.80M $3.41M $3.69M $3.04M $2.54M $2.83M
Total Equity $4.25M $11.06M $16.80M $3.41M $3.69M $3.04M $2.54M $2.83M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$8.88M -$5.66M -$8.24M -$10.10M -$8.49M
Depreciation & Amortization $102K $3.0K $8.0K $10K $8.0K
Stock-Based Compensation $564K $229K $271K $398K $57K
Change in Receivables -- $105K -$67K $1.0K -$66K
Change in Inventory $16.25M $0 $75K -$434K -$181K
Change in Payables $139K -$588K -$610K $534K $419K
Operating Cash Flow -$7.00M -$5.72M -$8.51M -$8.92M -$5.61M
Capital Expenditure -$38K $0 -$118K -$11K --
Free Cash Flow -$7.04M -$5.72M -$8.63M -$8.93M --
Investing Cash Flow -$705K $0 -$118K -$11K --
Common Stock Issued $2.34M $0 $8.51M -- $14.89M
Financing Cash Flow $18.35M $4.33M $8.51M -$528K $17.54M
Net Change in Cash $10.64M -$1.39M -$122K -$9.46M $11.93M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Net Income -$7.10M -$6.20M -$2.85M -$2.60M -$1.93M -$1.50M -$1.48M -$1.43M
Depreciation & Amortization $847K $449K $3.0K $0 $1.0K $1.0K $0 $1.0K
Stock-Based Compensation $133K $208K $149K $139K $176K $100K $63K $58K
Change in Receivables -- -- -- -$6.0K $0 $56K -$55K $7.0K
Change in Inventory $0 -$750K $16.17M $85K $0 $0 -$9.0K $35K
Change in Payables $10K $365K -$201K $231K -$204K $313K -$208K -$113K
Operating Cash Flow -$5.28M -$5.01M -$2.29M -$2.00M -$1.83M -$889K -$1.36M -$1.41M
Capital Expenditure -$57K -$7.0K -$25K -$10K -$3.0K $0 -- --
Free Cash Flow -$5.34M -$5.02M -$2.31M -$2.01M -$1.83M -$889K -- --
Investing Cash Flow -$57K -$7.0K -$149K -$10K -$20K -$526K -- --
Financing Cash Flow $231K -$44K $11.63M $4.27M $2.36M $82K $1.18M -$97K
Net Change in Cash -$5.11M -$5.06M $9.20M $2.27M $515K -$1.33M -$187K -$1.50M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- 0.3% 24.4% 16.2% -3.0%
Operating Margin -- -573.8% -701.1% -548.8% -448.1%
Net Profit Margin -- -725.0% -701.0% -548.7% -675.7%
Return on Equity (ROE) -52.9% -223.1% -230.3% -278.1% -64.0%
Return on Assets (ROA) -28.1% -201.5% -159.9% -171.8% -56.5%
Current Ratio 20.13x 9.70x 3.32x 2.83x 11.72x
Quick Ratio 20.13x 8.53x 2.78x 2.37x 11.37x
Debt to Equity -- -- 0.10x 0.15x 0.05x
Revenue Growth (YoY) -- -33.7% -36.1% +46.4% --
Gross Profit Growth (YoY) -- -99.3% -4.0% -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Gross Margin -- -- -- -58.1% -19.7% -22.3% 0.3% 25.7%
Operating Margin -- -- -- -1210.8% -1035.5% -847.3% -573.8% -671.1%
Net Profit Margin -- -- -- -1557.3% -1372.5% -1100.0% -725.0% -671.0%
Return on Equity (ROE) -441.6% -122.7% -52.9% -219.9% -172.0% -187.0% -223.1% -226.6%
Return on Assets (ROA) -57.7% -35.5% -28.1% -120.5% -140.7% -150.3% -201.5% -189.2%
Current Ratio 1.11x 3.31x 20.13x 5.86x 2.24x 1.70x 9.70x 5.65x
Quick Ratio 0.86x 3.02x 20.13x 5.86x 1.90x 1.29x 8.53x 4.34x
Debt to Equity 2.36x 0.92x -- -- -- -- -- --
Revenue Growth (YoY) -- -- -- +15.9% -38.6% -79.0% -49.6% -55.3%
Gross Profit Growth (YoY) -- -- -- -429.5% +80.0% -70.1% -4880.0% -59.3%
Source: SEC EDGAR CompanyFacts (CIK 0001787740) · from March 31, 2021 Data through June 30, 2026 · synced Nov 21, 2026, 05:13 UTC · Open in terminal